Invesco Ltd. - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 59 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q1 2023$436,042
-3.3%
425,0000.0%0.00%
Q4 2022$451,053
+7.1%
425,0000.0%0.00%
Q3 2022$421,0000.0%425,0000.0%0.00%
Q2 2022$421,000
-0.9%
425,0000.0%0.00%
Q1 2022$425,000
-4.3%
425,0000.0%0.00%
Q4 2021$444,000
+2.1%
425,0000.0%0.00%
Q3 2021$435,000
-1.1%
425,0000.0%0.00%
Q2 2021$440,000
-40.1%
425,000
-41.4%
0.00%
Q1 2021$734,000
-5.7%
725,0000.0%0.00%
Q4 2020$778,000
+2.2%
725,0000.0%0.00%
Q3 2020$761,000
-37.7%
725,000
-27.5%
0.00%
Q2 2020$1,222,000
+16.6%
1,000,0000.0%0.00%
Q1 2020$1,048,000
-0.9%
1,000,0000.0%0.00%
Q4 2019$1,057,000
-34.8%
1,000,000
-39.4%
0.00%
Q3 2019$1,622,000
-5.3%
1,650,0000.0%0.00%
Q2 2019$1,713,000
-37.6%
1,650,000
-38.5%
0.00%
-100.0%
Q1 2019$2,747,000
+2.9%
2,685,0000.0%0.00%0.0%
Q4 2018$2,670,000
-1.2%
2,685,000
+5.9%
0.00%0.0%
Q3 2018$2,702,000
+158.3%
2,535,000
+144.9%
0.00%
Q2 2018$1,046,0001,035,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q1 2023
NameSharesValueWeighting ↓
SHENKMAN CAPITAL MANAGEMENT INC 30,138,000$29,510,0003.72%
PFM Health Sciences, LP 45,910,000$46,002,0001.72%
Cheyne Capital Management (UK) LLP 2,320,000$2,330,0001.47%
ADVENT CAPITAL MANAGEMENT /DE/ 41,077,000$41,277,0000.66%
SSI INVESTMENT MANAGEMENT LLC 9,071,000$9,068,0000.50%
PALISADE CAPITAL MANAGEMENT, LP 14,548,000$14,612,0000.34%
RWC Asset Management LLP 7,500,000$7,552,0000.21%
KBC Group NV 400,000$40,316,0000.15%
PROSPECTOR PARTNERS LLC 1,000,000$1,000,0000.12%
MACKAY SHIELDS LLC 11,822,000$11,816,0000.10%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders